AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2021
Nov 1, 2021
33997_dirs_2021-11-01_977b8ab5-6af3-497c-9b6b-30e9ce138e7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2021-10-28
Reporting Person: CONLEY SHERYL L (Director)
More from Anika Therapeutics, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 18